Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients | Zendy

Milica Božić | Zendy; Àngels Betriu | Zendy; Marcelino Bermúdez-López | Zendy; Alberto Ortíz | Zendy; Elvira Fernández | Zendy; José Manuel Valdivielso | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients

Author(s) -

Milica Božić,

Àngels Betriu,

Marcelino Bermúdez-López,

Alberto Ortíz,

Elvira Fernández,

José Manuel Valdivielso

Publication year - 2018

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07980717

Subject(s) - medicine , odds ratio , kidney disease , risk factor , confidence interval , population , gastroenterology , dialysis , prospective cohort study , fibroblast growth factor 23 , atheroma , cardiology , parathyroid hormone , environmental health , calcium

Atherosclerosis is highly prevalent in CKD. The rate of progression of atherosclerosis is associated with cardiovascular events. Fibroblast growth factor 2 (FGF-2) is a member of the FGF family with potentially both protective and deleterious effects in the development of atherosclerosis. The role of circulating FGF-2 levels in the progression of atherosclerosis in CKD is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research